MENU ABOUT US MAKE A DONATION
The Epoch Times
Login
SEARCH
CLOSE
Help Center subscribe newsletter Newsstands Epoch Shop Digital Deals Gift
  • Editor’s Picks
  • SPECIAL SERIES
  • Special Coverage
  • LATEST ARTICLES
  • US
    • US News
    • US Features
    • Politics
    • Crime and Incidents
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
    • America Essay Contest
  • China
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World
    • Africa
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK
    • Australia
    • International
    • Middle East
  • Business & Economy
    • Companies
    • Economy
    • Markets
    • Real Estate
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Video
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • News
    • Aging
    • Fitness & Nutrition
    • Wellness
    • Traditional Wisdom
    • Mindset
SEARCH
  • EpochTV
  • US
  • Politics
  • China
  • World
  • Opinion
  • Business
  • Markets
  • Science
  • Bright
  • Health
  • Arts
  • Premium
  • Games
  • Sports
  • Livestream
  • More

Novartis

  • Novartis to Seek FDA Emergency Use Approval for New COVID-19 Therapy
    Novartis to Seek FDA Emergency Use Approval for New COVID-19 Therapy
    Novartis said on Jan. 10 that positive data from a clinical trial of COVID-19 therapeutic drug ensovibep has prompted the firm to exercise an option to in-licence the antiviral from ...
    January 10, 2022BY Tom Ozimek
  • Novartis Says US Court Upholds Gilenya Patent
    Novartis Says US Court Upholds Gilenya Patent
    ZURICH—Novartis AG said on Tuesday a U.S. court of appeals upheld the validity of a dosage regimen patent ...
    January 5, 2022BY Reuters
  • Novartis Options BeiGene Anti-Cancer Therapy in $1 Billion Deal
    Novartis Options BeiGene Anti-Cancer Therapy in $1 Billion Deal
    ZURICH—Novartis has signed an option, collaboration, and license agreement with BeiGene Ltd for anti-cancer therapy ociperlimab (BGB-A1217) to ...
    December 21, 2021BY Reuters
  • Roche Shareholders Approve Deal to Buy Novartis’s $20.7 Billion Stake
    Roche Shareholders Approve Deal to Buy Novartis’s $20.7 Billion Stake
    ZURICH—Roche shareholders voted overwhelmingly on Friday to support the $20.7 billion deal to buy Novartis's nearly one third ...
    November 27, 2021BY Reuters
  • Drugmakers Announce Trial of Jakafi for COVID-19 Patients on Ventilators
    Drugmakers Announce Trial of Jakafi for COVID-19 Patients on Ventilators
    Two drugmakers plan on testing a drug that blocks enzymes in COVID-19 patients on ventilators in the United States. ...
    May 6, 2020BY Zachary Stieber
  • Novartis Gains Permission From US to Test Hydroxychloroquine Against COVID-19
    Novartis Gains Permission From US to Test Hydroxychloroquine Against COVID-19
    Swiss drugmaker Novartis gained permission from the U.S. Food and Drug Administration to test hydroxychloroquine, a malaria drug ...
    April 20, 2020BY Zachary Stieber
  • Novartis Korea Executives Charged With Bribing Doctors
    Novartis Korea Executives Charged With Bribing Doctors
    Prosecutors have indicted a former chief executive of the South Korean unit of Novartis and five other former ...
    August 13, 2016BY The Associated Press
  • New Drug Could Reduce Cardiovascular Deaths (Video)
    New Drug Could Reduce Cardiovascular Deaths (Video)
    The new drug from Novartis could reduce cardiovascular deaths by 20 percent compared to other similar drugs.
    August 30, 2014BY Epoch Video
TOP NEWS
  • Health: Young Girls Are Over-Prescribed Birth Control Pills
    NEW By Jennifer Margulis
    Health: Young Girls Are Over-Prescribed Birth Control Pills
  • Indian Spokesperson: China Building Second Bridge in Disputed Border Area
    NEW By Aldgra Fredly
    Indian Spokesperson: China Building Second Bridge in Disputed Border Area
  • Boeing’s Starliner Capsule Docks With Space Station in Uncrewed Flight Test
    2hr By Reuters
    Boeing’s Starliner Capsule Docks With Space Station in Uncrewed Flight Test
  • NY State Supreme Court Reinstates Ban on Police Choke Holds During Arrests
    3hr By Caden Pearson
    NY State Supreme Court Reinstates Ban on Police Choke Holds During Arrests
  • Florida Court Overturns Ruling on DeSantis Redistricting Map
    5hr By Caden Pearson
    Florida Court Overturns Ruling on DeSantis Redistricting Map
  • Australians Vote in Hotly Contested Federal Election
    5hr By Aldgra Fredly
    Australians Vote in Hotly Contested Federal Election
  • CDC Advises Doctors to Be on Alert for Monkeypox as WHO Confirms Outbreaks in 11 Countries
    5hr By Mimi Nguyen Ly
    CDC Advises Doctors to Be on Alert for Monkeypox as WHO Confirms Outbreaks in 11 Countries
  • Feds Halt Sales of Homemade Guns Before August Rule Is Implemented
    6hr By Beth Brelje
    Feds Halt Sales of Homemade Guns Before August Rule Is Implemented
  • Incumbent Oregon District Attorneys Fend Off Well-Funded Progressive Challengers
    7hr By Cara Ding
    Incumbent Oregon District Attorneys Fend Off Well-Funded Progressive Challengers
  • Biden Appoints John Kirby as NSC Coordinator for Strategic Communications at White House
    7hr By Caden Pearson
    Biden Appoints John Kirby as NSC Coordinator for Strategic Communications at White House
The Epoch Times
Help Center subscribe newsletter Newsstands Epoch Shop Digital Deals Gift
  • Editor’s Picks
  • SPECIAL SERIES
  • Special Coverage
  • LATEST ARTICLES
You deserve to hear the truth.
  • Contact Editorial
  • Contact Customer Care
  • Advertise
  • Copyrights and Permissions
  • PR and Media Inquiries
  • Media Statements
  • About Us
  • RSS Feeds
  • Terms of Services
  • Privacy Policy
  • Copyright Policy
  • Data Disclaimer
  • Digital Newspaper
  • Our Story
  • Subscribe
  • Careers
36 COUNTRIES, 22 LANGUAGES
  • Bulgarian
  • English
  • Chinese
  • Spanish
  • Japanese
  • Korean
  • Indonesian
  • French
  • German
  • Italian
  • Portuguese
  • Swedish
  • Dutch
  • Russian
  • Ukrainian
  • Romanian
  • Czech
  • Slovak
  • Polish
  • Turkish
  • Persian
  • Vietnamese
DOWNLOAD OUR APP
iOS Android
  • US
    • US News
    • US Features
    • Politics
    • Crime and Incidents
    • New York
    • San Francisco
    • Los Angeles
  • Opinion
    • Thinking About China
    • Viewpoints
    • Unbridled Evil: The Corrupt Reign of Jiang Zemin in China
    • The Reader’s Turn
    • America Essay Contest
  • China
    • US-China Relations
    • Chinese Regime
    • Business & Economy
    • Chinese Culture
    • China Human Rights
    • Social Issues
    • Organ Harvesting in China
  • World
    • Africa
    • Americas
    • Asia & Pacific
    • Canada
    • Europe
    • UK
    • Australia
    • International
    • Middle East
  • Business & Economy
    • Companies
    • Economy
    • Markets
    • Real Estate
  • ARTS & CULTURE
    • Fine Arts & Craftsmanship
    • Performing Arts
    • Books
    • Traditional Culture
    • Shen Yun Special Coverage
    • Film & TV
  • Science
    • News
    • Space
    • Environment
  • Tech
    • Tech News
    • Tech Products & Reviews
    • Social Media
  • Sports
  • Video
    • American Thought Leaders
    • China Insider
    • Crossroads
  • Bright
    • Lifestyle
    • Inspired
    • Family & Education
    • Personal Finance
    • American Essence
  • Entertainment
    • Film & TV
    • Entertainment News
  • Health
    • News
    • Aging
    • Fitness & Nutrition
    • Wellness
    • Traditional Wisdom
    • Mindset
Copyright © 2000 - 2022
Back Top
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Use. More informationI accept×